Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMG-PEG 2000 (DMG-PEG2000) is a lipid excipient that has been used in combination with other lipids in the formation of lipid nanoparticles. Formulations containing DMG-PEG 2000 have been used in the development of lipid nanoparticles for the delivery of mRNA-based vaccines.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
10 mg | 在庫あり | ¥ 7,000 | |||
25 mg | 在庫あり | ¥ 10,000 | |||
50 mg | 在庫あり | ¥ 14,500 | |||
100 mg | 在庫あり | ¥ 21,500 | |||
200 mg | 在庫あり | ¥ 33,500 | |||
500 mg | 在庫あり | ¥ 66,500 |
説明 | DMG-PEG 2000 (DMG-PEG2000) is a lipid excipient that has been used in combination with other lipids in the formation of lipid nanoparticles. Formulations containing DMG-PEG 2000 have been used in the development of lipid nanoparticles for the delivery of mRNA-based vaccines. |
別名 | DMG-PEG2000 |
分子量 | 587.927 |
分子式 | C34H69NO6 |
CAS No. | 160743-62-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 1mg/ml, Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
DMG-PEG 2000 160743-62-4 Others DMG-PEG2000 Inhibitor therapy T2D lPEI/DNA nanoparticle type II diabete A549 HepG2 inhibit HeLa DMG-PEG-2000 DMGPEG 2000 293T nucleic acid DMG PEG 2000 inhibitor